Drug intelligence / Profile preview

Dermacyd Tina Gel Sweet Flower

Development stage
Phase 3
Lead developer
Sanofi
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Topical
01

Overview

Dermacyd Tina Gel Sweet Flower is a specialized intimate hygiene product developed by Sanofi's consumer healthcare division. Formulated as a topical gel, its primary active components are lactic acid and lactoserum (whey), which are designed to mimic and support the natural protective environment of the female intimate area. The mechanism of action involves maintaining a physiological acidic pH, which is essential for the stability of the local microbiota and the prevention of dysbiosis. By reinforcing the acid mantle, the product helps inhibit the colonization and proliferation of pathogenic bacteria and fungi. The "D-Sanofi" designation is associated with clinical safety evaluations, such as compatibility studies, which assess the product's potential for dermal irritability and sensitization across various skin phototypes to ensure high tolerability for daily use.

Brand names
Dermacyd Tina Gel Sweet FlowerDermacyd
Other names
Dermacyd Tina

Beyond the preview

Go deeper on Dermacyd Tina Gel Sweet Flower.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermacyd Tina Gel Sweet Flower.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call